Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells

Cancer Research

Volumn 61, Issue 3, 2001, Pages 1073-1079

  Fan, Liju ^a   Iyer, Jaya ^b   Zhu, Shaoxian ^c   Frick, Kevin K ^b   Wada, Randall K ^d   Eskenazi, Allen E ^a   Berg, Patricia E ^e   Ikegaki, Naohiko ^f   Kennett, Roger H ^g   Frantz, Christopher N ^h  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g WHEATON COLLEGE   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DEFEROXAMINE MESYLATE; HYDROXYUREA; IRON CHELATE; ONCOPROTEIN; RIBONUCLEOTIDE REDUCTASE;

APOPTOSIS; ARTICLE; CHILDHOOD CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; IRON CHELATION; NEUROBLASTOMA CELL; NICK END LABELING; ONCOGENE C FOS; ONCOGENE C MYB; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REPORTER GENE; TUMOR CELL; TUMOR GROWTH;

APHIDICOLIN; APOPTOSIS; DEFEROXAMINE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GENES, REPORTER; HUMANS; HYDROXYUREA; INHIBITORY CONCENTRATION 50; IRON; IRON CHELATING AGENTS; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENES; RNA, MESSENGER; SUBSTRATE SPECIFICITY; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035114278     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
2. Increased N-myc expression following progressive growth of human neuroblastoma
3. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma
4. MYCN protein expression as a predictor of neuroblastoma prognosis
5. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma
6. Transcription regulation by dimerization: Two sides to an incestuous relationship
7. Modulation of N-myc expression alters the invasiveness of neuroblastoma
8. Role of RR in inhibition of mammalian cell growth by potent iron chelators
9. Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells
10. Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: Changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis
11. Deferoxamine: A reversible S-phase inhibitor of human lymphocyte proliferation
12. Iron deprivation decreases RR activity and DNA synthesis
13. Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: The Children's Cancer Study Group experience
14. Regulation of N-myc gene expression in human neuroblastoma
15. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells
16. Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities
17. Multiple mechanisms for transcription regulation of the myc gene family in small-cell lung cancer
18. A simplification of the nuclear run-on transcription assay
19. Plate-derived growth factor-simulated c-myc RNA accumulation in MG-63 human osteosarcoma cells is independent of both protein kinase A and protein kinase C
20. Mechanism of action of hydroxyurea
21. Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-α
22. Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate
23. Expression of human transferrin receptor
24. Identification and characterization of the protein encoded by the human N-myc oncogene
25. Alternative processing of RNA transcribed from NMYC
26. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells
27. Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression
28. N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts
29. Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression
30. MycN sensitizes neuroblastoma cells for drug-induced apoptosis
31. Cdc25 cell-cycle phosphatase as a target of c-myc
32. c-myc induces apoptosis and cell cycle progression by separable, yet overlapping pathways
33. A unique glucose-dependent apoptotic pathway induced by c-myc
34. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells
35. Retinoids in neuroblastoma therapy: Distinct biological properties of 9-cis- and all-trans-retinoic acid
36. Iron regulatory elements (IREs): A family of mRNA non-coding sequences
37. MatInd and MatInspector: New, fast and versatile tools for detection of consensus matches in nucleotide sequence data
38. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation
39. The heme-responsive element of the mouse heme oxygenase-1 gene is an AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors
40. Mechanism of metallothionein gene regulation by hemehemopexin: Role of protein kinase C, reactive oxygen species, and cis-acting elements
41. Reduction and loss of the iron center in the reaction of the small subunit of mouse RR with hydroxyurea
42. Induction of apoptosis in chronic myelogenous leukemia lymphocytes by hydroxyurea and adriamycin
43. Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells
44. Enhanced c-fos expression after intracellular iron deprivation
45. AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis
46. Iron deprivation results in an increase in p53 expression
47. Absence of p53 gene mutations in primary neuroblastomas
48. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization
49. 1checkpoint after DNA damage
50. N-myc amplification and its relationship to experimental therapy